Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332 (11 March), doi:10.1136/bmj.332.7541.0-a
Palliative care inpatients at risk of thromboembolism find low molecular weight heparin more acceptable than wearing antiembolic stockings. In a qualitative study (p 577), Noble and colleagues interviewed 28 patients with advanced malignancy who were receiving low molecular weight heparin. Many of them thought that thrombophylaxis had a positive effect on their quality of life and gave them a feeling of safety. Thromboprophylaxis guidelines are urgently needed for palliative care inpatient units and hospices, say the authors.
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?